In mouse models of GBM, CAR T cells labeled with 89Zr-oxine showed that IL13Rα2-CAR T cells were labeled successfully without reduced efficacy from labeling and labeled CAR T cells were successful in assessing cytokine production and tumor cytotoxicity as well as in vivo antitumor activity [39]. This evidence concerns the gene IL13RA2 and glioblastoma.